Metlife INC Form 4 insider transactions

Michel Khalaf, President & CEO of MetLife, reports acquisition and disposal of common stock due to restricted stock unit awards and performance share payouts.

EVP & Chief Financial Officer of MetLife, John D. McCallion, reports acquisition and disposal of MetLife common stock.

Ramy Tadros, President of U.S. Business at MetLife, reports acquisition and disposal of company stock related to restricted stock units and performance share payouts.

Director Carlos M. Gutierrez reports acquiring 535 shares of MetLife common stock as part of director compensation and disposing of 18,807 shares held indirectly through a trust.

Director David L. Herzog reports acquiring 535 shares of MetLife common stock at $81.78 and holding shares through a trust.

Director Edward J. Kelly III acquired 535 shares of MetLife common stock on January 2, 2025, through the company's deferred compensation plan for non-management directors.

Director Mark A. Weinberger reports acquiring 535 shares of MetLife common stock as part of non-management director compensation.

Director Laura J. Hay reports changes in beneficial ownership of MetLife common stock, including acquisition and disposal of shares.

Director Cheryl W. Grise acquired 535 shares of MetLife common stock on January 2, 2025, through the company's deferred compensation plan for non-management directors.

Director Denise M. Morrison reports acquiring 535 shares of MetLife common stock as part of non-management director compensation.

Robert Glenn Hubbard, a director at MetLife, acquired 918 shares of common stock at $81.78 per share under the company's deferred compensation plan.

Director Jeh C. Johnson acquired 535 shares of MetLife common stock at $81.78 per share under the company's deferred compensation plan.

Director Carla A. Harris acquired 535 shares of MetLife common stock on January 2, 2025, under the company's deferred compensation plan for non-management directors.

Director Diana McKenzie acquired 535 shares of MetLife common stock at $81.78 per share on January 2, 2025, according to a Form 4 filing.

Director William E. Kennard increased his holdings in MetLife through the acquisition of 535 shares at $81.78 per share on January 2, 2025.

Director Jeh C. Johnson reports acquiring 33 shares of MetLife common stock through dividend reinvestment.

Director David L. Herzog increased his holdings in MetLife through a dividend reinvestment in the company's deferred compensation plan.

Director William E. Kennard reports acquiring 271 shares of MetLife common stock through dividend reinvestment.

Director Laura J. Hay acquired 13 shares of MetLife common stock through dividend reinvestment on December 16, 2024.

Director Diana McKenzie increased her holdings in MetLife through a dividend reinvestment plan, acquiring 132 shares at $82.74 each.

Director Cheryl W. Grise increased her holdings in MetLife through a dividend reinvestment plan, acquiring 536 shares at $82.74 each.

Director Robert Glenn Hubbard acquired 579 shares of MetLife common stock through dividend reinvestment at a price of $82.74 per share, increasing his total holdings to 96,410 shares.

Director Edward J. Kelly III reports acquiring 232 shares of MetLife common stock through dividend reinvestment.

Director Carla A. Harris reports acquiring 16 shares of MetLife common stock through dividend reinvestment.

Marlene Debel, EVP & Chief Risk Officer at MetLife, exercised stock options and sold shares on December 13, 2024.

MetLife's CEO, Michel Khalaf, exercised stock options and sold a portion of the acquired shares to cover costs and taxes on December 13, 2024.

Director Edward J. Kelly III acquired 535 shares of MetLife common stock at $81.78 per share through the company's deferred compensation plan.

Director Jeh C. Johnson acquired 535 shares of MetLife common stock at $81.78 per share on October 1, 2024, through the company's deferred compensation plan.

Carla A. Harris, a director at MetLife, acquired 535 shares of common stock at $81.78 per share on October 1, 2024, under the company's deferred compensation plan.

Director William E. Kennard reports acquiring 535 shares of MetLife common stock at $81.78 per share and discloses holdings in the MetLife Policyholder Trust.